NCT07356245 2026-01-21
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
Ohio State University Comprehensive Cancer Center
Bambino Gesù Hospital and Research Institute
Novartis
St. Petersburg State Pavlov Medical University